Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Chronic Gastritis Workup

  • Author: Akiva J Marcus, MD, PhD; Chief Editor: BS Anand, MD  more...
 
Updated: Jun 29, 2016
 

Approach Considerations

The diagnosis of chronic gastritis can only be established on histologic grounds. Therefore, histologic assessment of endoscopic biopsies is essential. Identification of the underlying cause of chronic gastritis and assessment of specific complications can require several laboratory tests.

Failure to diagnose the underlying cause of chronic gastritis correctly may result in unnecessary morbidity. Failure to identify and treat H pylori infection in the presence of peptic ulcers may result in ulcer recurrence and complications.

Next

Laboratory Studies

Atrophic gastritis may be assessed by measuring the ratio of pepsinogen I (PGI, PGA) to pepsinogen II (PGII, PGC) in the serum. PGI and PGII are synthesized and secreted by gastric chief cells. After being secreted into the gastric lumen, they are converted into proteolytic active pepsins. The level of PGI in the serum decreases as gastric chief cells are lost during gastric atrophy, resulting in a decreased PGI/PGII ratio. Gastric carcinoma occurs, especially the intestinal type, usually in association with severe atrophic gastritis.

Measuring the levels of PGI and PGII and the PGI/PGII ratio in the serum is useful in screening for atrophic gastritis and gastric cancer in regions with a high incidence of these diseases. Pepsinogen determination is especially useful in epidemiologic studies; however, the reported sensitivity and specificity of the assay are relatively low (84.6% and 73.5%, respectively).

A rapid urease test should be done on gastric biopsy tissue. Bacterial culture of gastric biopsy tissue is usually performed in the research setting or to assess antibiotic susceptibility in patients in whom first-line eradication therapy fails.

The following test results suggest the diagnosis of autoimmune gastritis:

  • Antiparietal and anti–intrinsic factor (IF) antibodies in the serum
  • Achlorhydria, both basal and stimulated, and hypergastrinemia
  • Low serum cobalamin (vitamin B-12) levels (<100 pg/mL)
  • Possible abnormal result on Schilling test (this can be corrected by IF)
Previous
Next

Endoscopy

Magnifying endoscopy is helpful for analyzing the subepithelial microvascular architecture, as well as the mucosal surface microstructure, without tissue biopsy.[89] Using this technique, investigators from the United Kingdom were able to describe the normal gastric microvasculature pattern and identify characteristic patterns in 2 cases of autoimmune atrophic gastritis.[90]

Upper gastrointestinal (GI) endoscopy is essential for establishing the diagnosis of gastritis. Although some studies have suggested that H pylori infection can be determined on the basis of unique endoscopic features, particularly the presence of antral nodularity, whether there is a specific relation between H pylori and macroscopic features remains controversial. The endoscopic findings in chronic H pylori infection may include areas of intestinal metaplasia.

Multiple biopsy specimens should be obtained. Tissue sampling from the gastric antrum, incisura, and corpus is essential to establish the topography of gastritis and to identify atrophy and intestinal metaplasia, which usually is patchy. It is recommended that biopsy samples of the gastric body and those from the antrum and incisura be submitted in separate containers for pathologic evaluation.

Endoscopic findings in granulomatous gastritis include mucosal nodularity with cobblestoning, multiple aphthous ulcers, linear or serpiginous ulcerations, thickened antral folds, antral narrowing, hypoperistalsis, and duodenal strictures. Extensive gastric involvement may resemble linitis plastica.

Endoscopic findings in lymphocytic gastritis include enlarged folds and aphthoid erosions, with the appearance of small, heaped-up, volcanolike mounds pocked with a central crater. This endoscopic pattern has also been described as varioliform gastritis.

The endoscopic findings of reflux and chemical gastropathy are those of a gastric mucosa that is red or has red streaks with areas of apparent hemorrhage.

A meta-analysis has shown that for individuals who undergo endoscopy for dyspepsia, the most common finding is erosive esophagitis (though the prevalence was lower when the Rome criteria were used to define dyspepsia), followed by peptic ulcers.[91]

Previous
Next

Biopsy

The standard method of determining whether H pylori is the underlying cause of gastritis is histologic identification of the organism. Histologic examination is also used to evaluate the degree and distribution of gastritis. Obtain at least 2 biopsies from the gastric antrum, 2 from the corpus, and 1 from the incisura.

Special stains to identify H pylori (eg, Warthin-Starry, Giemsa, or Genta) or immunohistochemistry may be necessary when the organisms are not observed and chronic gastritis is obvious.

At late stages of infection with extensive atrophic gastritis, the numbers of H pylori organisms are markedly decreased because intestinal metaplasia creates an unfavorable environment for H pylori. In these cases, other tests (eg, the urea breath test) and serologic indicators of infection may provide evidence for H pylori infection.

Previous
Next

Histologic Findings

H pylori–associated gastritis can display different levels of severity. H pylori organisms are found within the gastric mucous layer and frequently accumulate in groups at the apical side of gastric surface cells, occasionally in the lower portions of the gastric foveolae, and rarely within the deeper areas of the mucosa in association with glandular cells (see the images below).

Helicobacter pylori–caused chronic active gastriti Helicobacter pylori–caused chronic active gastritis. Genta stain (×20). Multiple organisms (brown) are visibly adherent to gastric surface epithelial cells.
Chronic gastritis associated with Helicobacter pyl Chronic gastritis associated with Helicobacter pylori infection. Numerous plasma cells in the lamina propria.

Patients with typical infections initially develop chronic active gastritis in which H pylori is observed in both the antrum and the corpus (usually in greater numbers in the antrum). Polymorphonuclear leukocytes (PMNs) infiltrate the lamina propria, glands, surface epithelium, and foveolar epithelium, occasionally spilling into the lumen and forming small microabscesses. Lymphoid aggregates and occasional well-developed lymphoid follicles are observed expanding the lamina propria of the mucosa, and occasional lymphocytes permeate the epithelium.

In disease of longer duration, significant loss of gastric glands is observed, in a condition known as gastric atrophy. Gastric atrophy may result from the loss of gastric epithelial cells that were not replaced by appropriate cell proliferation, or it may result from replacement of the epithelium with intestinal-type epithelium (intestinal metaplasia).

In advanced stages of atrophy associated with chronic H pylori infection, both the corpus and antrum display an extensive replacement by intestinal metaplasia that is associated with the development of hypochlorhydria. With expansion of intestinal metaplasia, the number of H pylori organisms that are detected in the stomach decreases because H pylori is excluded from areas of metaplastic epithelium.

The histologic changes of autoimmune atrophic gastritis vary in different phases of the disease. During an early phase, multifocal diffuse infiltration of the lamina propria by mononuclear cells and eosinophils and focal T-cell infiltration of oxyntic glands with glandular destruction are seen. Focal mucous neck cell hyperplasia (pseudopyloric metaplasia) and hypertrophic changes of parietal cells are also observed.

During the florid phase of the disease, increased lymphocytic inflammation, oxyntic gland atrophy, and focal intestinal metaplasia occur. The end stage is characterized by diffuse involvement of the gastric corpus and fundus by chronic atrophic gastritis associated with little intestinal metaplasia. The antrum is spared.

Granulomatous gastritis predominantly affects the gastric antrum. In early stages, the only findings may be isolated granulomas in the mucosa and submucosa. In later stages of the disease, inflammation extends to the muscularis propria, and fibrosis may be prominent. Granulomas associated with tuberculosis are typically caseating. Poorly formed granulomas can also be observed in syphilitic involvement of the stomach in the tertiary stage of the disease.

Noninfectious causes of gastric granulomas typically result in noncaseating granulomas; such causes include the following:

  • Crohn disease
  • Sarcoidosis
  • Isolated granulomas

Crohn disease affecting the stomach consists of patchy inflammation with pit or gland abscesses. Lymphoid aggregates are common. Severe cases may show fissures, ulcers, transmural inflammation, and serosal and submucosal fibrosis. Noncaseating epithelioid granulomas may be observed. Diffuse inflammatory infiltration in the lamina propria and glandular atrophy occur. Gastric involvement is almost invariably synchronous with Crohn disease in the ileum or colon.

Sarcoidosis and isolated granulomas are characterized by bland granulomas with mild associated inflammation. Although sarcoidosis affecting the stomach typically coexists with sarcoidosis involving other organs, isolated granulomatous gastritis only affects the stomach and is a diagnosis of exclusion.

Cytomegalovirus (CMV) infection of the stomach is observed in patients with underlying immunosuppression. Histologically, typical intranuclear eosinophilic inclusions and, occasionally, smaller intracytoplasmic inclusions are found (see the image below). Patchy, mild, inflammatory infiltrate is observed in the lamina propria. Viral inclusions are present in gastric epithelial cells and in endothelial or mesenchymal cells in the lamina propria. Severe mucosal necrosis may result in severe ulceration.

Chronic gastritis. Typical cytomegalovirus inclusi Chronic gastritis. Typical cytomegalovirus inclusions in the lamina propria capillary endothelial cells. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.

Herpes simplex causes basophilic intranuclear inclusions in epithelial cells. M avium-intracellulare infections are characterized by diffuse infiltration of the lamina propria by histiocytes, which rarely form granulomas (see the image below).

Chronic gastritis. Mycobacterium avium-intracellul Chronic gastritis. Mycobacterium avium-intracellulare in the gastric lamina propria macrophages. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.

In cases of gastritis associated with graft versus host disease (GVHD), the stomach is rarely affected. Typical epithelial cell apoptosis and pit or gland dilatation occur. Pit and gland abscesses and nonspecific inflammation of the lamina propria may be observed. In severe disease, glandular atrophy, focal intestinal metaplasia, and severe mucosal denudation may occur.

In eosinophilic gastritis, the mucosa shows intense patchy infiltration by numerous eosinophils, with occasional pit abscesses. The infiltrate typically contains 10-50 eosinophils per high-power field, as well as plasma cells. Mucosal edema, congestion, and necrosis of the surface epithelium with small erosions may be present. Mucosal infiltration by a bandlike eosinophil infiltrate in the lower portion of the lamina propria above the muscularis mucosa characterizes eosinophilic gastroenteritis associated with connective tissue disorders.

In lymphocytic gastritis, the lamina propria and pit epithelium are infiltrated by large numbers of small mature T lymphocytes. Abundant T lymphocytes typically permeate the surface epithelium. A diagnosis can be rendered when 30 or more lymphocytes are observed per 100 consecutive epithelial cells, and performing the counts in biopsies from the gastric corpus is recommended.

In chemical gastropathy, changes are more prominent in the prepyloric region but may extend to involve the oxyntic mucosa. Histologic changes associated with chronic bile reflux and long-term nonsteroidal anti-inflammatory drug (NSAID) intake include mucosal edema, congestion, fibromuscular hyperplasia in the lamina propria, and pit or foveolar hyperplasia that may create a corkscrew pattern. Cellular proliferation is associated with reactive nuclear features and epithelial reduction of mucin. Epithelial changes occur with a paucity of inflammatory cells.

In radiation gastritis, radiation causes degenerative changes in epithelial cells and a nonspecific chronic inflammatory infiltrate in the lamina propria. These changes are reversible in a period of a few months. Higher amounts of radiation cause permanent mucosal damage, with atrophy of fundic glands, mucosal erosions, and capillary hemorrhage. Associated submucosal endarteritis results in mucosal ischemia and secondary ulcer development.

In ischemic gastritis, chronic ischemia may produce superficial erosions and, rarely, deep ulcers. Inflammatory changes are observed in the context of ulcer repair. Ischemic ulcers are more frequently antral and are often surrounded by multiple erosions.

Idiopathic granulomatous gastritis demonstrates histopathology similar to sarcoid involvement of the stomach. Antral narrowing caused by transmural, noncaseating, granulomatous inflammation occurs. Inflammation and fibrosis are usually limited to the mucosa. Idiopathic granulomatous gastritis may represent isolated or limited forms of gastric sarcoid or Crohn disease.

Previous
 
 
Contributor Information and Disclosures
Author

Akiva J Marcus, MD, PhD Attending Gastroenterologist, West Palm Hospital

Akiva J Marcus, MD, PhD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, New York Society for Gastrointestinal Endoscopy, International Society for Stem Cell Research

Disclosure: Nothing to disclose.

Coauthor(s)

David Greenwald, MD Professor of Clinical Medicine, Fellowship Program Director, Department of Medicine, Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine

David Greenwald, MD is a member of the following medical societies: Alpha Omega Alpha, New York Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Chief Editor

BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine

BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Acknowledgements

Simmy Bank, MD Chair, Professor, Department of Internal Medicine, Division of Gastroenterology, Long Island Jewish Hospital, Albert Einstein College of Medicine

Disclosure: Nothing to disclose.

Franco Bazzoli, MD Professor, Department of Internal Medicine and Gastroenterology, University of Bologna, Italy

Franco Bazzoli, MD is a member of the following medical societies: American Gastroenterological Association

Disclosure: Nothing to disclose.

Maria P Dore, MD Associate Professor, Department of Medicine, Institute of Internal Medicine, University of Sassari, Italy

Maria P Dore, MD is a member of the following medical societies: American Gastroenterological Association

Disclosure: Nothing to disclose.

Sandeep Mukherjee, MB, BCh, MPH, FRCPC Associate Professor, Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Nebraska Medical Center; Consulting Staff, Section of Gastroenterology and Hepatology, Veteran Affairs Medical Center

Sandeep Mukherjee, MB, BCh, MPH, FRCPC is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Merck Honoraria Speaking and teaching; Ikaria Pharmaceuticals Honoraria Board membership

Tushar Patel, MB, ChB Professor of Medicine, Ohio State University Medical Center

Tushar Patel, MB, ChB is a member of the following medical societies: American Association for the Study of Liver Diseases and American Gastroenterological Association

Disclosure: Nothing to disclose.

Antonia R Sepulveda, MD, PhD Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine; Director of Surgical Pathology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania

Antonia R Sepulveda, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Gastroenterological Association, American Society for Investigative Pathology, College of American Pathologists, and United States and Canadian Academy of Pathology

Disclosure: Genentech Honoraria Consulting; Leica Honoraria Consulting

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

References
  1. Szabo IL, Cseko K, Czimmer J, Mozsik G. Diagnosis of gastritis – Review from early pathological evaluation to present day management. Mozsik G, ed. Current Topics in Gastritis - 2012. Rijeka, Croatia: In Tech; 2012. Chap 1. [Full Text].

  2. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4. 1(8336):1273-5. [Medline].

  3. Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: population-based study among 9,444 older adults from Germany. Int J Cancer. 2009 Dec 15. 125(12):2918-22. [Medline].

  4. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct. 20(10):1161-81. [Medline].

  5. Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med. 2008 Oct. 132(10):1586-93. [Medline].

  6. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995. 9 Suppl 2:33-9. [Medline].

  7. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010 Apr 29. 362(17):1597-604. [Medline].

  8. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994 Jul 6. 272(1):65-9. [Medline].

  9. Shiotani A, Nurgalieva ZZ, Yamaoka Y, Graham DY. Helicobacter pylori. Med Clin North Am. 2000 Sep. 84(5):1125-36, viii. [Medline].

  10. Ihan A, Pinchuk IV, Beswick EJ. Inflammation, immunity, and vaccines for Helicobacter pylori infection. Helicobacter. 2012 Sep. 17 Suppl 1:16-21. [Medline]. [Full Text].

  11. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007 Jul. 133(1):288-308. [Medline].

  12. Zalewska-Ziob M, Adamek B, Strzelczyk JK, et al. TNF-alpha expression in gastric mucosa of individuals infected with different virulent Helicobacter pylori strains. Med Sci Monit. 2009 Jun. 15(6):BR166-71. [Medline].

  13. Wallace JL. Gastric ulceration: critical events at the neutrophil--endothelium interface. Can J Physiol Pharmacol. 1993 Jan. 71(1):98-102. [Medline].

  14. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 1990 Apr. 85(4):394-8. [Medline].

  15. Graham DY, Go MF, Lew GM, Genta RM, Rehfeld JF. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol. 1993 Aug. 28(8):690-4. [Medline].

  16. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013 Jun. 11(6):385-99. [Medline]. [Full Text].

  17. Gao L, Weck MN, Nieters A, Brenner H. Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression?. Eur J Cancer. 2009 Nov. 45(16):2860-6. [Medline].

  18. Wang SY, Shen XY, Wu CY, et al. Analysis of whole genomic expression profiles of Helicobacter pylori related chronic atrophic gastritis with IL-1B-31CC/-511TT genotypes. J Dig Dis. 2009 May. 10(2):99-106. [Medline].

  19. Paniagua GL, Monroy E, Rodriguez R, et al. Frequency of vacA, cagA and babA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Ann Clin Microbiol Antimicrob. 2009 Apr 30. 8:14. [Medline]. [Full Text].

  20. Antonio-Rincon F, Lopez-Vidal Y, Castillo-Rojas G, et al. Pathogenicity island cag, vacA and IS605 genotypes in Mexican strains of Helicobacter pylori associated with peptic ulcers. Ann Clin Microbiol Antimicrob. 2011 May 13. 10:18. [Medline]. [Full Text].

  21. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013 Jan. 42(1):5-18. [Medline].

  22. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001 Sep 13. 345(11):784-9. [Medline].

  23. Zhao B, Zhao J, Cheng WF, et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol. 2014 Mar. 48(3):241-7. [Medline].

  24. Delgado JS, Landa E, Ben-Dor D. Granulomatous gastritis and Helicobacter pylori infection. Isr Med Assoc J. 2013 Jun. 15(6):317-8. [Medline].

  25. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013 Sep. 10(9):529-41. [Medline].

  26. Hung OY, Maithel SK, Willingham FF, Farris AB 3rd, Kauh JS. Hypergastrinemia, type 1 gastric carcinoid tumors: diagnosis and management. J Clin Oncol. 2011 Sep 1. 29(25):e713-5. [Medline].

  27. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995 Mar. 90(3):338-52. [Medline].

  28. Conn DA. Detection of type I and type II antibodies to intrinsic factor. Med Lab Sci. 1986 Apr. 43(2):148-51. [Medline].

  29. Ectors NL, Dixon MF, Geboes KJ, Rutgeerts PJ, Desmet VJ, Vantrappen GR. Granulomatous gastritis: a morphological and diagnostic approach. Histopathology. 1993 Jul. 23(1):55-61. [Medline].

  30. Wu TT, Hamilton SR. Lymphocytic gastritis: association with etiology and topology. Am J Surg Pathol. 1999 Feb. 23(2):153-8. [Medline].

  31. Wolber R, Owen D, DelBuono L, Appelman H, Freeman H. Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology. 1990 Feb. 98(2):310-5. [Medline].

  32. Feeley KM, Heneghan MA, Stevens FM, McCarthy CF. Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol. 1998 Mar. 51(3):207-10. [Medline]. [Full Text].

  33. Haot J, Hamichi L, Wallez L, Mainguet P. Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study. Gut. 1988 Sep. 29(9):1258-64. [Medline]. [Full Text].

  34. Lambert R, Andre C, Moulinier B, Bugnon B. Diffuse varioliform gastritis. Digestion. 1978. 17(2):159-67. [Medline].

  35. Makinen JM, Niemela S, Kerola T, Lehtola J, Karttunen TJ. Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment. World J Gastroenterol. 2003 Dec. 9(12):2706-10. [Medline].

  36. Ruget O, Burtin P, Cerez H, Cales P, Boyer J. Chronic diarrhea associated with villous atrophy and lymphocytic gastritis, caused by ticlopidine. Gastroenterol Clin Biol. 1992. 16(3):290. [Medline].

  37. Sheikh RA, Prindiville TP, Pecha RE, Ruebner BH. Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol. 2009 May 7. 15(17):2156-61. [Medline]. [Full Text].

  38. Sell A, Jensen TS. Acute gastric ulcers induced by radiation. Acta Radiol Ther Phys Biol. 1966 Aug. 4(4):289-97. [Medline].

  39. Flobert C, Cellier C, Landi B, et al. [Severe hemorrhagic gastritis of radiation origin]. Gastroenterol Clin Biol. 1998 Feb. 22(2):232-4. [Medline].

  40. Quentin V, Dib N, Thouveny F, L'Hoste P, Croue A, Boyer J. Chronic ischemic gastritis: case report of a difficult diagnosis and review of the literature. Endoscopy. 2006 May. 38(5):529-32. [Medline].

  41. Chambon JP, Bianchini A, Massouille D, Perot C, Lancelevee J, Zerbib P. Ischemic gastritis: a rare but lethal consequence of celiac territory ischemic syndrome. Minerva Chir. 2012 Oct. 67(5):421-8. [Medline].

  42. Singhal AV, Sepulveda AR. Helicobacter heilmannii gastritis: a case study with review of literature. Am J Surg Pathol. 2005 Nov. 29(11):1537-9. [Medline].

  43. Hasegawa Y, Goto A, Nishimura S, Sukawa Y, Fujii K, Suzuki K. Cytomegalovirus gastritis after treatment with rituximab. Endoscopy. 2009 Jul. 41(S 02):E199. [Medline].

  44. Genta RM. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol. 2005 Nov. 22(4):273-83. [Medline].

  45. Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis?. Am J Surg Pathol. 1996 Apr. 20(4):462-70. [Medline].

  46. Maeng L, Lee A, Choi K, Kang CS, Kim KM. Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol. 2004 Jul. 28(7):941-5. [Medline].

  47. Leung ST, Chandan VS, Murray JA, Wu TT. Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol. 2009 May. 33(5):788-98. [Medline].

  48. Galiatsatos P, Gologan A, Lamoureux E. Autistic enterocolitis: fact or fiction?. Can J Gastroenterol. 2009 Feb. 23(2):95-8. [Medline]. [Full Text].

  49. Rosenberg JJ. Helicobacter pylori. Pediatr Rev. 2010 Feb. 31(2):85-6; discussion 86. [Medline].

  50. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000 Apr. 181(4):1359-63. [Medline].

  51. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000 Sep. 29(3):559-78. [Medline].

  52. Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014 Mar. 29(3):520-8. [Medline]. [Full Text].

  53. Nabwera HM, Nguyen-Van-Tam JS, Logan RF, Logan RP. Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3-15 years and risk factors for infection. Eur J Gastroenterol Hepatol. 2000 May. 12(5):483-7. [Medline].

  54. Sathar MA, Gouws E, Simjee AE, Mayat AM. Seroepidemiological study of Helicobacter pylori infection in South African children. Trans R Soc Trop Med Hyg. 1997 Jul-Aug. 91(4):393-5. [Medline].

  55. Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. J Gerontol A Biol Sci Med Sci. 2009 Feb. 64(2):272-9. [Medline]. [Full Text].

  56. Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter. 2010 Aug. 15(4):273-8. [Medline]. [Full Text].

  57. Tsai CJ, Perry S, Sanchez L, Parsonnet J. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol. 2005 Aug 15. 162(4):351-7. [Medline].

  58. Lin DB, Lin JB, Chen CY, Chen SC, Chen WK. Seroprevalence of Helicobacter pylori infection among schoolchildren and teachers in Taiwan. Helicobacter. 2007 Jun. 12(3):258-64. [Medline].

  59. Rubio CA, Befritz R, Eriksson B, Christensson B, Duvander A, Larsson B. The topographic distribution of lymphocytic gastritis in gastrectomy specimens. APMIS. 1991 Sep. 99(9):815-9. [Medline].

  60. Jaskiewicz K, Price SK, Zak J, Louwrens HD. Lymphocytic gastritis in nonulcer dyspepsia. Dig Dis Sci. 1991 Aug. 36(8):1079-83. [Medline].

  61. Tanih NF, Dube C, Green E, et al. An African perspective on Helicobacter pylori: prevalence of human infection, drug resistance, and alternative approaches to treatment. Ann Trop Med Parasitol. 2009 Apr. 103(3):189-204. [Medline].

  62. Gao L, Weck MN, Raum E, Stegmaier C, Rothenbacher D, Brenner H. Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany. Int J Epidemiol. 2010 Feb. 39(1):129-34. [Medline].

  63. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb. 123(2):183.e1-9. [Medline].

  64. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005 Aug. 18(4):300-5. [Medline].

  65. de Vega Santos T, Zamarron Moreno A, Pascual de Pablo E, Lopez Lopez C. [Pernicious anemia and primary hyperparathyroidism]. Rev Clin Esp. 1995 Mar. 195(3):200-1. [Medline].

  66. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992 Mar. 102(3):760-6. [Medline].

  67. Sugiyama T, Nishikawa K, Komatsu Y, et al. Attributable risk of H pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H pylori ulcers?. Dig Dis Sci. 2001 Feb. 46(2):307-10. [Medline].

  68. O'Donohoe JM, Sullivan PB, Scott R, Rogers T, Brueton MJ, Barltrop D. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children. Acta Paediatr. 1996 Aug. 85(8):961-4. [Medline].

  69. Lindkvist P, Asrat D, Nilsson I, et al. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand J Infect Dis. 1996. 28(2):181-4. [Medline].

  70. Gold BD, Colletti RB, Abbott M, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2000 Nov. 31(5):490-7. [Medline].

  71. Hall CA, Beebe RT. Early onset of pernicious anaemia in two siblings: genetic and autoimmune aspects. Br J Haematol. 1973 Dec. 25(6):751-6. [Medline].

  72. Annibale B, Lahner E, Fave GD. Diagnosis and management of pernicious anemia. Curr Gastroenterol Rep. 2011 Dec. 13(6):518-24. [Medline].

  73. Min KU, Metcalfe DD. Eosinophilic gastroenteritis. Immunol Allergy Clin North Am. 1991. 11:799-813.

  74. Ndip RN, Malange AE, Akoachere JF, MacKay WG, Titanji VP, Weaver LT. Helicobacter pylori antigens in the faeces of asymptomatic children in the Buea and Limbe health districts of Cameroon: a pilot study. Trop Med Int Health. 2004 Sep. 9(9):1036-40. [Medline].

  75. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014 Apr 10. 345(2):196-202. [Medline].

  76. Iacopini F, Consolazio A, Bosco D, et al. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter. 2003. 8(5):503-12. [Medline].

  77. Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am. 2000 Sep. 29(3):705-51. [Medline].

  78. Macintyre G, Kooi C, Wong F, Anderson R. On the membrane cytopathology of mouse hepatitis virus infection as probed by a semi-permeable translation-inhibiting drug. Adv Exp Med Biol. 1990. 276:67-72. [Medline].

  79. Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009. 44(5):365-71. [Medline].

  80. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008 Aug 2. 372(9636):392-7. [Medline].

  81. Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther. 2005 May 1. 21(9):1121-6. [Medline].

  82. Yamamoto K, Kato M, Takahashi M, et al. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter. 2011 Jun. 16(3):210-6. [Medline].

  83. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997 Nov 13. 337(20):1441-8. [Medline].

  84. Sjoblom SM, Sipponen P, Jarvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993 Jan. 34(1):28-32. [Medline]. [Full Text].

  85. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013 Jan 10. 368(2):149-60. [Medline].

  86. Arvanitakis C. Functional and morphological abnormalities of the small intestinal mucosa in pernicious anemia--a prospective study. Acta Hepatogastroenterol (Stuttg). 1978 Aug. 25(4):313-8. [Medline].

  87. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014. 120:915-26. [Medline].

  88. Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol. 2008 Apr. 103(4):982-9. [Medline].

  89. Tahara T, Shibata T, Nakamura M, et al. Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc. 2009 Aug. 70(2):246-53. [Medline].

  90. Anagnostopoulos GK, Ragunath K, Shonde A, Hawkey CJ, Yao K. Diagnosis of autoimmune gastritis by high resolution magnification endoscopy. World J Gastroenterol. 2006 Jul 28. 12(28):4586-7. [Medline].

  91. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010 Oct. 8(10):830-7, 837.e1-2. [Medline].

  92. Graham DY, Belson G, Abudayyeh S, Osato MS, Dore MP, El-Zimaity HM. Twice daily (mid-day and evening) quadruple therapy for H pylori infection in the United States. Dig Liver Dis. 2004 Jun. 36(6):384-7. [Medline].

  93. Malfertheiner P, Megraud F, O'Morain C, et al for the European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb. 16(2):167-80. [Medline].

  94. Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol. 1994 Nov. 47(11):968-72. [Medline]. [Full Text].

  95. Griffiths AP, Wyatt J, Jack AS, Dixon MF. Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma. J Clin Pathol. 1994 Dec. 47(12):1123-4. [Medline]. [Full Text].

  96. Ingle SB, Hinge CR, Dakhure S, Bhosale SS. Isolated gastric Crohn's disease. World J Clin Cases. 2013 May 16. 1(2):71-3. [Medline]. [Full Text].

  97. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch. 1998 Jan. 432(1):49-52. [Medline].

  98. Shkolnik LE, Shin RD, Brabeck DM, Rothman RD. Symptomatic gastric sarcoidosis in a patient with pulmonary sarcoidosis in remission. BMJ Case Rep. 2012 Jul 13. 2012:[Medline].

  99. Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology. 2009 Jul. 20(4):569-74. [Medline].

 
Previous
Next
 
Helicobacter pylori–caused chronic active gastritis. Genta stain (×20). Multiple organisms (brown) are visibly adherent to gastric surface epithelial cells.
Chronic gastritis associated with Helicobacter pylori infection. Numerous plasma cells in the lamina propria.
Granulomatous chronic gastritis. Noncaseating granulomas in the lamina propria. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.
Chronic gastritis. Mycobacterium avium-intracellulare in the gastric lamina propria macrophages. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.
Chronic gastritis. Typical cytomegalovirus inclusions in the lamina propria capillary endothelial cells. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.
Chronic gastritis. Chemical gastropathy. Image courtesy of Sydney Finkelstein, MD, PhD, University of Pittsburgh.
Lymphocytic chronic gastritis. Gastric epithelium is studded with numerous lymphocytes (left). Intraepithelial lymphocytes are T-cell lymphocytes shown by immunoreactivity to CD3 (brown stain, right).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.